Cytosorbents (CTSO) Gains from Sales and Divestitures (2019 - 2026)
Cytosorbents posted quarterly Gains from Sales and Divestitures of $12500.0 for Q1 2026, down 64.29% year-on-year from $35000.0 in Q1 2025, and down 95.28% on a QoQ basis from $264835.0 in Q4 2025.
Cytosorbents (CTSO) has 8 years of Gains from Sales and Divestitures data on file, last reported at $12500.0 in Q1 2026.
- For the quarter ending Q1 2026, Gains from Sales and Divestitures fell 64.29% year-over-year to $12500.0; the trailing twelve-month figure through Mar 2026 stood at $12500.0 (down 64.29% YoY), and the FY2025 full-year result was $264835.0, up 562.09% from the prior year.
- Gains from Sales and Divestitures for Q1 2026 stood at $12500.0, down from $264835.0 in the prior quarter.
- Across five years, Gains from Sales and Divestitures topped out at $297169.0 in Q3 2024 and bottomed at $12500.0 in Q1 2026.
- The 5-year median for Gains from Sales and Divestitures is $45000.0 (2022), against an average of $85047.6.
- Peak annual rise in Gains from Sales and Divestitures reached 562.09% in 2025, while the deepest fall reached 88.22% in 2025.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $45000.0 in 2022, then soared by 38.89% to $62500.0 in 2023, then slumped by 36.0% to $40000.0 in 2024, then surged by 562.09% to $264835.0 in 2025, then plunged by 95.28% to $12500.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $12500.0 (Q1 2026), $264835.0 (Q4 2025), and $35000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Cytosorbents | 28.81 Mn | 24.01 Mn | 6.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12,500.00 |
| Mar 31, 2026 | 12,500.00 |
| Dec 31, 2025 | 264,835.00 |
| Dec 31, 2025 | 264,835.00 |
| Sep 30, 2025 | 35,000.00 |
| Sep 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Jun 30, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Mar 31, 2025 | 35,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 297,169.00 |
| Sep 30, 2024 | 297,169.00 |
| Jun 30, 2024 | 20,000.00 |
| Jun 30, 2024 | 20,000.00 |
| Dec 31, 2023 | 62,500.00 |
| Dec 31, 2023 | 62,500.00 |
| Sep 30, 2023 | 204,087.00 |
| Sep 30, 2023 | 204,087.00 |
| Jun 30, 2023 | 78,589.00 |
| Jun 30, 2023 | 78,589.00 |
| Dec 31, 2022 | 45,000.00 |
| Dec 31, 2022 | 45,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Sep 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Jun 30, 2022 | 45,000.00 |
| Mar 31, 2022 | 56,034.00 |
| Mar 31, 2022 | 56,034.00 |
| Dec 31, 2021 | 196,525.00 |
| Dec 31, 2021 | 196,525.00 |
| Sep 30, 2021 | 196,525.00 |
| Sep 30, 2021 | 196,525.00 |
| Jun 30, 2021 | 140,490.00 |
| Jun 30, 2021 | 140,490.00 |
| Mar 31, 2021 | 61,902.00 |
| Mar 31, 2021 | 61,902.00 |
| Dec 31, 2020 | 162,000.00 |
| Dec 31, 2020 | 162,000.00 |
| Sep 30, 2020 | 162,000.00 |
| Sep 30, 2020 | 162,000.00 |
| Jun 30, 2020 | 105,968.00 |
| Jun 30, 2020 | 105,968.00 |
| Mar 31, 2020 | 105,968.00 |
| Mar 31, 2020 | 105,968.00 |
| Dec 31, 2019 | 157,904.00 |
| Dec 31, 2019 | 157,904.00 |
| Sep 30, 2019 | 157,904.00 |
| Sep 30, 2019 | 157,904.00 |
| Jun 30, 2019 | 97,806.00 |
| Jun 30, 2019 | 97,806.00 |